Deals
Galderma Said to Agree to Buy Q-Med to Gain Smoother
This article is for subscribers only.
Galderma SA, the Swiss maker of Cetaphil skin creams, agreed to buy Sweden’s Q-Med AB to add products that smooth wrinkles and enhance breasts, according to a person with direct knowledge of the transaction.
An agreement has been signed and the deal may be announced as soon as this week, said the person, who declined to be identified because the negotiations were confidential. Q-Med, based in Uppsala, Sweden, has a market value of 6.58 billion kronor ($952 million). Galderma, founded in 1981, is owned by L’Oreal SA and Nestle SA.